Combined inhibition of PI3K delta and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.